Professional Relations Committee
>> Professional Relations Committee Members
>>CPT Committee
 

Professional Relations Position Papers and Responses 2008 Suggestions to the SACGHS regarding New Priorities (April 2008) Verbal Comments to the SACGHS Regarding Oversight of Genetic Testing Draft Report (February 2008)   2007 Comments to the SACGHS Task Force Draft Report Regarding Oversight of Genetic Testing (December 2007) AMP Position regarding Direct Access Genetic Testing (Direct to Consumer Genetic Testing) (June 2007) Letter to Sen. Dodd endorsing the "Medical Education Affordability Act"  (March 2007) Comments to the SACGHS (March 2007) Response to FDA regarding IVDMIA Draft Guidance document (March 2007) Response to FDA regarding ASR Draft Guidance document (March 2007) Comments to CLIAC regarding introducing a Genetics Specialty to the CLIA regulations (Feb 2007) Letter to the House and Senate supporting the Genetics Information Nondiscrimination Act (GINA) (January 2007)   >>2006 and Earlier

The AMP Professional Relations Committee is the primary liaison between AMP and other organizations. Major responsibilities of the Committee include: Communicating and coordinating activities with the appropriate government, patient, and professional organizations to inform policy and reimbursement discussions that influence the practice of molecular pathology Developing AMP positions on emerging issues affecting molecular pathology. The Professional Relations Committee has interacted with a wide variety of entities, including health care reimbursement groups, and U.S. Federal Agencies such as FDA, CDC, DHHS. More information about the activities of the Professional Relations Committee can be found in the Committee Report section of the AMP Newsletter.

05/01/2008